Peptide Nucleic Acid as Therapeutic Agent
With a repeating N-(2-aminoethyl)-glycine peptide backbone coupled to purine and pyrimidine nucleobases via a linker, PNA are synthetic analogues of DNA. PNA-based technology has received a lot of interest as a viable method for gene modification due to the unique qualities of PNA, including resistance to enzymatic digestion, increased bio stability, and excellent hybridization affinity toward DNA and RNA. However, inadequate intracellular absorption presents a significant obstacle to the use of PNA. To improve PNA delivery and ensure that it reaches the appropriate spot, some solutions have been devised
Related Conference of Peptide Nucleic Acid as Therapeutic Agent
Peptide Nucleic Acid as Therapeutic Agent Conference Speakers
Recommended Sessions
- A New Approach to Determining the Nucleic Acid Sequence
- Function of Nucleic Acid
- Types of RNA
- Artificial Nucleic Acid
- DNA Damage and Repair
- Effect of Nucleic Acid on Protein Synthesis
- Enzymes for Nucleic Acids
- Infectious Disease
- Molecular Biology
- Molecular Structure of Nucleic Acid
- Nucleic Acid as a Genetic Material
- Nucleic Acid Bases
- Nucleic Acid Probes
- Nucleic Acid Recognition
- Peptide Nucleic Acid as Therapeutic Agent
- Recombinant DNA Technology
- RNA Processing and Protein Synthesis
- Thermodynamics of Nucleic Acids
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- Biochemistry - Glycobiology 2025 (Germany)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene regulation and Cell Signalling - Structural Biology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Hybrid approaches in Structure prediction - Structural Biology 2025 (Germany)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular biology techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)